CAMK2N1 and posterior cortical atrophy: CAMK2N1, characterized as an inhibitor of CaMKII (calcium/calmodulin-dependent protein kinase II) [32–35], has been identified as a downstream transcriptional target of PRMT5 in PCa cells.